Delivery Order SPE2DB24D2018-SPE2DB25FWUJ2

Award Date 4/30/25
Potential Completion Date 5/1/25
Potential Value $4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Jardiance 10 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The $6,134.12 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of February 6, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of Jardiance 10 mg tablets to fulfill pharmaceutical needs. The $5,786.75 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 19, 2024. The contract has an ultimate completion date of December 20, 2024 and is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of Jardiance 10mg tablets, a medication used to treat type 2 diabetes, to the Defense Logistics Agency (DLA). The contract, valued at $89,799.17, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a firm fixed-price delivery order with an ultimate completion date of December 1, 2022. The contract was awarded through full and open competition, with no set-aside...
This federal contract award is for the delivery of pharmaceutical products, specifically Jardiance 10 mg tablets, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for a total ceiling value of $3,983.95. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which is valued at $999,999,999 and...
This federal contract award is for the delivery of Jardiance 25 mg tablets to the Defense Logistics Agency (DLA). The contract, valued at $37,989.64, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a...
This federal contract award is for the delivery of Jardiance 25 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $7,763.13, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is a $999,999,999 IDC running through November 2026. This IDC serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,527.11 firm-fixed-price delivery order is for the supply of Jardiance 25 mg tablets, a medication used to treat diabetes. The contract has an ultimate completion date of May 5, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of Jardiance 10 mg tablets to support military healthcare programs. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $13,147.78 and runs through March 31, 2025. It is a firm fixed-price delivery order contract, with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award is for the delivery of Jardiance 25 mg tablets to the Defense Logistics Agency (DLA). The contract, valued at $1,154.11, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for...
This federal contract award is for the delivery of Jardiance 10 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The award, valued at $17,418.55, was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 6, 2024. The contract has a completion date of November 7, 2024 and is a firm fixed-price delivery order. There is no set-aside designation indicated. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB24D2018
    Indefinite Delivery Contract
  • SPE2DB24D2018-SPE2DB25FWUJ2
    Delivery Order

This federal contract award is for the delivery of Jardiance 10 mg tablets, a diabetes medication, to the Defense Logistics Agency (DLA). The fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, and has a ceiling value of $3,995.10. The contract has an ultimate completion date of May 1, 2025.

AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and U.S. Coast Guard.

The contract award does not have a set-aside designation, indicating that it was open to full and open competition.

Generated 8/3/25, 1:13 AM